Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Thomas Jefferson University
PharmaEssentia Japan K.K.
Incyte Corporation
Roswell Park Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center